{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:12:30Z","timestamp":1791141150821,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11030-025-11184-9","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T02:25:18Z","timestamp":1744597518000},"page":"3517-3535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting Poly (ADP-ribose) polymerase-1 (PARP-1) for DNA repair mechanism through QSAR-based virtual screening and MD simulation"],"prefix":"10.1007","volume":"29","author":[{"given":"Kun","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"5","key":"11184_CR1","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.eururo.2016.05.043","volume":"70","author":"MC Wong","year":"2016","unstructured":"Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY et al (2016) Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol 70(5):862\u2013874. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.043","journal-title":"Eur Urol"},{"issue":"1","key":"11184_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/gerona\/gls135","volume":"68","author":"BT Howrey","year":"2013","unstructured":"Howrey BT, Kuo Y-F, Lin Y-L, Goodwin JS (2013) The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States. J Gerontol Series A Biomed Sci Med Sci 68(1):56\u201361. https:\/\/doi.org\/10.1093\/gerona\/gls135","journal-title":"J Gerontol Series A Biomed Sci Med Sci"},{"issue":"17","key":"11184_CR3","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S (2022) Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules 27(17):5730. https:\/\/doi.org\/10.3390\/molecules27175730","journal-title":"Molecules"},{"issue":"2","key":"11184_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/excr.2001.5263","volume":"342","author":"D D'Amours","year":"1999","unstructured":"D\u2019Amours D, Desnoyers S, D\u2019Silva I, Poirier GG (1999) Poly (ADP-ribosyl) ation reactions in the regulation of nuclear functions. Biochem J 342(2):249\u2013268. https:\/\/doi.org\/10.1006\/excr.2001.5263","journal-title":"Biochem J"},{"issue":"7035","key":"11184_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB et al (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434(7035):917\u2013921. https:\/\/doi.org\/10.1038\/nature03445","journal-title":"Nature"},{"issue":"6\u20137","key":"11184_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/emmm.200900041","volume":"1","author":"AM Mendes-Pereira","year":"2009","unstructured":"Mendes-Pereira AM, Martin SA, Brough R, McCarthy A, Taylor JR, Kim JS et al (2009) Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. EMBO Mol Med 1(6\u20137):315\u2013322. https:\/\/doi.org\/10.1002\/emmm.200900041","journal-title":"EMBO Mol Med"},{"issue":"16","key":"11184_CR7","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","volume":"66","author":"N McCabe","year":"2006","unstructured":"McCabe N, Turner NC, Lord CJ, Kluzek K, Bia\u0142kowska A, Swift S et al (2006) Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly (ADP-ribose) polymerase inhibition. Can Res 66(16):8109\u20138115. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0140","journal-title":"Can Res"},{"issue":"6","key":"11184_CR8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.mam.2013.04.001","volume":"34","author":"C Thomas","year":"2013","unstructured":"Thomas C, Tulin AV (2013) Poly-ADP-ribose polymerase: machinery for nuclear processes. Mol Aspects Med 34(6):1124\u20131137. https:\/\/doi.org\/10.1016\/j.mam.2013.04.001","journal-title":"Mol Aspects Med"},{"key":"11184_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fonc.2013.00290","volume":"3","author":"AN Weaver","year":"2013","unstructured":"Weaver AN, Yang ES (2013) Beyond DNA repair: additional functions of PARP-1 in cancer. Front Oncol 3:290. https:\/\/doi.org\/10.3389\/fonc.2013.00290","journal-title":"Front Oncol"},{"issue":"6082","key":"11184_CR10","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.1216338","volume":"336","author":"M-F Langelier","year":"2012","unstructured":"Langelier M-F, Planck JL, Roy S, Pascal JM (2012) Structural basis for DNA damage\u2013dependent poly (ADP-ribosyl) ation by human PARP-1. Science 336(6082):728\u2013732. https:\/\/doi.org\/10.1126\/science.1216338","journal-title":"Science"},{"issue":"4","key":"11184_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.tibs.2009.12.003","volume":"35","author":"MO Hottiger","year":"2010","unstructured":"Hottiger MO, Hassa PO, L\u00fcscher B, Sch\u00fcler H, Koch-Nolte F (2010) Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem Sci 35(4):208\u2013219. https:\/\/doi.org\/10.1016\/j.tibs.2009.12.003","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"11184_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ijc.33918","volume":"150","author":"C Zong","year":"2022","unstructured":"Zong C, Zhu T, He J, Huang R, Jia R, Shen J (2022) PARP mediated DNA damage response, genomic stability and immune responses. Int J Cancer 150(11):1745\u20131759. https:\/\/doi.org\/10.1002\/ijc.33918","journal-title":"Int J Cancer"},{"key":"11184_CR13","doi-asserted-by":"publisher","first-page":"118975","DOI":"10.1016\/j.lfs.2020.118975","volume":"267","author":"K Thapa","year":"2021","unstructured":"Thapa K, Khan H, Sharma U, Grewal AK, Singh TG (2021) Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases. Life Sci 267:118975. https:\/\/doi.org\/10.1016\/j.lfs.2020.118975","journal-title":"Life Sci"},{"issue":"9","key":"11184_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","volume":"30","author":"J Mateo","year":"2019","unstructured":"Mateo J, Lord C, Serra V, Tutt A, Balma\u00f1a J, Castroviejo-Bermejo M et al (2019) A decade of clinical development of PARP inhibitors in perspective. Ann Oncol 30(9):1437\u20131447. https:\/\/doi.org\/10.1093\/annonc\/mdz192","journal-title":"Ann Oncol"},{"issue":"8","key":"11184_CR15","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1093\/nar\/gkz120","volume":"47","author":"EE Alemasova","year":"2019","unstructured":"Alemasova EE, Lavrik OI (2019) Poly (ADP-ribosyl) ation by PARP1: reaction mechanism and regulatory proteins. Nucleic Acids Res 47(8):3811\u20133827. https:\/\/doi.org\/10.1093\/nar\/gkz120","journal-title":"Nucleic Acids Res"},{"key":"11184_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117485","volume":"180","author":"S-H Zhang","year":"2024","unstructured":"Zhang S-H, Su Y, Zheng M, Zeng N, Sun J-X, Xu J-Z et al (2024) Design, synthesis and biological evaluation of dual inhibitors targeting AR\/AR-Vs and PARP1 in castration resistant prostate cancer therapy. Biomed Pharmacother 180:117485. https:\/\/doi.org\/10.1016\/j.biopha.2024.117485","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"11184_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.euo.2023.07.013","volume":"7","author":"C Messina","year":"2024","unstructured":"Messina C, Giunta EF, Signori A, Rebuzzi SE, Banna GL, Maniam A et al (2024) Combining PARP inhibitors and androgen receptor signalling inhibitors in metastatic prostate cancer: a quantitative synthesis and meta-analysis. Europ Urol Oncol 7(2):179\u2013188. https:\/\/doi.org\/10.1016\/j.euo.2023.07.013","journal-title":"Europ Urol Oncol"},{"issue":"1","key":"11184_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13073-024-01370-z","volume":"16","author":"A Herencia-Ropero","year":"2024","unstructured":"Herencia-Ropero A, Llop-Guevara A, Staniszewska AD, Dom\u00e8nech-Viv\u00f3 J, Garc\u00eda-Galea E, Moles-Fern\u00e1ndez A et al (2024) The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1\/2-associated cancer models. Genome Med 16(1):107. https:\/\/doi.org\/10.1186\/s13073-024-01370-z","journal-title":"Genome Med"},{"key":"11184_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40268-020-00301-8","volume":"20","author":"S Boussios","year":"2020","unstructured":"Boussios S, Abson C, Moschetta M, Rassy E, Karathanasi A, Bhat T et al (2020) Poly (ADP-Ribose) polymerase inhibitors: talazoparib in ovarian cancer and beyond. Drugs R&D 20:55\u201373. https:\/\/doi.org\/10.1007\/s40268-020-00301-8","journal-title":"Drugs R&D"},{"issue":"3","key":"11184_CR20","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","volume":"55","author":"S Dara","year":"2022","unstructured":"Dara S, Dhamercherla S, Jadav SS, Babu CM, Ahsan MJ (2022) Machine learning in drug discovery: a review. Artif Intell Rev 55(3):1947\u20131999. https:\/\/doi.org\/10.1007\/s10462-021-10058-4","journal-title":"Artif Intell Rev"},{"key":"11184_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI (2015) Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J 13:8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005","journal-title":"Comput Struct Biotechnol J"},{"key":"11184_CR22","doi-asserted-by":"publisher","first-page":"101911","DOI":"10.1016\/j.jsps.2023.101911","volume":"32","author":"M Aloui","year":"2024","unstructured":"Aloui M, Er-Rajy M, Imtara H, Goudzal A, Zarougui S, El Fadili M (2024) QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton\u2019s tyrosine kinase (BTK) inhibitors. Saudi Pharm J 32:101911. https:\/\/doi.org\/10.1016\/j.jsps.2023.101911","journal-title":"Saudi Pharm J"},{"issue":"10","key":"11184_CR23","doi-asserted-by":"publisher","first-page":"105193","DOI":"10.1016\/j.arabjc.2023.105193","volume":"16","author":"M Er-rajy","year":"2023","unstructured":"Er-rajy M, Mujwar S, Imtara H, Alshawwa SZ, Nasr FA, Zarougui S et al (2023) Design of novel anti-cancer agents targeting COX-2 inhibitors based on computational studies. Arab J Chem 16(10):105193. https:\/\/doi.org\/10.1016\/j.arabjc.2023.105193","journal-title":"Arab J Chem"},{"issue":"2","key":"11184_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/CAD.0000000000001492","volume":"35","author":"M Er-Rajy","year":"2024","unstructured":"Er-Rajy M, Faris A, Zarougui S, Elhallaoui M (2024) Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation. Anticancer Drugs 35(2):117\u2013128. https:\/\/doi.org\/10.1097\/CAD.0000000000001492","journal-title":"Anticancer Drugs"},{"issue":"D1","key":"11184_CR25","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(D1):D1100\u2013D1107. https:\/\/doi.org\/10.1093\/nar\/gkr777","journal-title":"Nucleic Acids Res"},{"key":"11184_CR26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.4c00863","author":"J Sieg","year":"2024","unstructured":"Sieg J, Feldmann CW, Hemmerich J, Stork C, Sandfort F, Eiden P et al (2024) MolPipeline: a python package for processing molecules with RDKit in scikit-learn. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.4c00863","journal-title":"J Chem Inf Model"},{"issue":"8","key":"11184_CR27","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.3390\/biomedicines11082251","volume":"11","author":"M Shahab","year":"2023","unstructured":"Shahab M, Zheng G, Khan A, Wei D, Novikov AS (2023) Machine learning-based virtual screening and molecular simulation approaches identified novel potential inhibitors for cancer therapy. Biomedicines 11(8):2251. https:\/\/doi.org\/10.3390\/biomedicines11082251","journal-title":"Biomedicines"},{"issue":"7","key":"11184_CR28","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"CW Yap","year":"2011","unstructured":"Yap CW (2011) PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32(7):1466\u20131474. https:\/\/doi.org\/10.1002\/jcc.21707","journal-title":"J Comput Chem"},{"issue":"11","key":"11184_CR29","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1021\/ci400466r","volume":"53","author":"S Riniker","year":"2013","unstructured":"Riniker S, Fechner N, Landrum GA (2013) Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing. J Chem Inf Model 53(11):2829\u20132836. https:\/\/doi.org\/10.1021\/ci400466r","journal-title":"J Chem Inf Model"},{"key":"11184_CR30","doi-asserted-by":"publisher","unstructured":"Hong H, Liu J, Guo W, Dong F, Lee M, Xu L, et al. Decision forest\u2014a machine learning algorithm for QSAR modeling. QSAR in Safety Evaluation and Risk Assessment. Elsevier; 2023. p. 35\u201348. https:\/\/doi.org\/10.1016\/B978-0-443-15339-6.00029-1","DOI":"10.1016\/B978-0-443-15339-6.00029-1"},{"issue":"24","key":"11184_CR31","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1093\/bioinformatics\/btz421","volume":"35","author":"CL Morais","year":"2019","unstructured":"Morais CL, Santos MC, Lima KM, Martin FL (2019) Improving data splitting for classification applications in spectrochemical analyses employing a random-mutation Kennard-Stone algorithm approach. Bioinformatics 35(24):5257\u20135263. https:\/\/doi.org\/10.1093\/bioinformatics\/btz421","journal-title":"Bioinformatics"},{"issue":"5","key":"11184_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/1062936X.2023.2214871","volume":"34","author":"K H\u00e9berger","year":"2023","unstructured":"H\u00e9berger K (2023) Selection of optimal validation methods for quantitative structure\u2013activity relationships and applicability domain. SAR QSAR Environ Res 34(5):415\u2013434. https:\/\/doi.org\/10.1080\/1062936X.2023.2214871","journal-title":"SAR QSAR Environ Res"},{"issue":"5","key":"11184_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26(5):694\u2013701. https:\/\/doi.org\/10.1002\/qsar.200610151","journal-title":"QSAR Comb Sci"},{"key":"11184_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chemolab.2015.04.013","volume":"145","author":"K Roy","year":"2015","unstructured":"Roy K, Kar S, Ambure P (2015) On a simple approach for determining applicability domain of QSAR models. Chemom Intell Lab Syst 145:22\u201329. https:\/\/doi.org\/10.1016\/j.chemolab.2015.04.013","journal-title":"Chemom Intell Lab Syst"},{"issue":"11","key":"11184_CR35","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2013ligand discovery for everyone. J Chem Inf Model 55(11):2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"key":"11184_CR36","doi-asserted-by":"publisher","DOI":"10.1201\/9781003343981-2","author":"HF Alharbi","year":"2024","unstructured":"Alharbi HF, Bhupathyraaj M, Mohandoss K, Chacko L, Rani KRV (2024) An overview of artificial intelligence-driven pharmaceutical functionality. Artif Intell Pharm Sci. https:\/\/doi.org\/10.1201\/9781003343981-2","journal-title":"Artif Intell Pharm Sci"},{"issue":"6","key":"11184_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s0014-5793(03)01362-0","volume":"46","author":"T Kinoshita","year":"2004","unstructured":"Kinoshita T (2004) Inhibitor-induced structural change of the active site of human poly (ADP-ribose) polymerase. Nihon Kessho Gakkaishi. 46(6):421\u2013425. https:\/\/doi.org\/10.1016\/s0014-5793(03)01362-0","journal-title":"Nihon Kessho Gakkaishi."},{"issue":"1","key":"11184_CR38","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2019","unstructured":"Tian C, Kasavajhala K, Belfon KA, Raguette L, Huang H, Migues AN et al (2019) ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16(1):528\u2013552. https:\/\/doi.org\/10.1021\/acs.jctc.9b00591","journal-title":"J Chem Theory Comput"},{"key":"11184_CR39","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1016\/j.csbj.2024.10.051","volume":"23","author":"A Sethi","year":"2024","unstructured":"Sethi A, Agrawal N, Brezovsky J (2024) Impact of water models on the structure and dynamics of enzyme tunnels. Comput Struct Biotechnol J 23:3946\u20133954. https:\/\/doi.org\/10.1016\/j.csbj.2024.10.051","journal-title":"Comput Struct Biotechnol J"},{"key":"11184_CR40","doi-asserted-by":"publisher","first-page":"116164","DOI":"10.1016\/j.molliq.2021.116164","volume":"335","author":"D Kumar","year":"2021","unstructured":"Kumar D, Meena M, Kumari K, Kumar R, Bahadur I, Jain P et al (2021) Exploring the effect of temperature on inhibition of non-structural protease 3 of Chikungunya virus using molecular dynamics simulations and thermodynamics parameters. J Mol Liq 335:116164. https:\/\/doi.org\/10.1016\/j.molliq.2021.116164","journal-title":"J Mol Liq"},{"issue":"1","key":"11184_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13065-024-01152-z","volume":"18","author":"A Ajmal","year":"2024","unstructured":"Ajmal A, Alkhatabi HA, Alreemi RM, Alamri MA, Khalid A, Abdalla AN et al (2024) Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target. BMC Chem 18(1):57. https:\/\/doi.org\/10.1186\/s13065-024-01152-z","journal-title":"BMC Chem"},{"key":"11184_CR42","doi-asserted-by":"publisher","unstructured":"Salomon-Ferrer R, Gotz AW, Poole D, Le Grand S, Walker RC. (2013). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J Chem Theory Comput. 9(9): 3878\u201388. https:\/\/doi.org\/10.1021\/ct400314y","DOI":"10.1021\/ct400314y"},{"issue":"7","key":"11184_CR43","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE III (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9(7):3084\u20133095. https:\/\/doi.org\/10.1021\/ct400341p","journal-title":"J Chem Theory Comput"},{"issue":"4","key":"11184_CR44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli G, Del Rio A, Degliesposti G, Sgobba M (2010) Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem 31(4):797\u2013810. https:\/\/doi.org\/10.1002\/jcc.21372","journal-title":"J Comput Chem"},{"issue":"12","key":"11184_CR45","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1021\/jm049081q","volume":"48","author":"B Kuhn","year":"2005","unstructured":"Kuhn B, Gerber P, Schulz-Gasch T, Stahl M (2005) Validation and use of the MM-PBSA approach for drug discovery. J Med Chem 48(12):4040\u20134048. https:\/\/doi.org\/10.1021\/jm049081q","journal-title":"J Med Chem"},{"issue":"10","key":"11184_CR46","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1021\/acs.jcim.8b00532","volume":"58","author":"H Yang","year":"2018","unstructured":"Yang H, Sun L, Wang Z, Li W, Liu G, Tang Y (2018) ADMETopt: a web server for ADMET optimization in drug design via scaffold hopping. J Chem Inf Model 58(10):2051\u20132056. https:\/\/doi.org\/10.1021\/acs.jcim.8b00532","journal-title":"J Chem Inf Model"},{"key":"11184_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7756-7_14","author":"DE Pires","year":"2018","unstructured":"Pires DE, Kaminskas LM, Ascher DB (2018) Prediction and optimization of pharmacokinetic and toxicity properties of the ligand. Comput Drug Discov Design. https:\/\/doi.org\/10.1007\/978-1-4939-7756-7_14","journal-title":"Comput Drug Discov Design"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11184-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11184-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:01:55Z","timestamp":1752152515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11184-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["11184"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11184-9","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}